Aspen Pharmacare Holdings LimitedJSE: APN

Aspen Pharmacare Expects HY HEPS Of 400.1 To 432.4 Cents

· Issued by Aspen Pharmacare Holdings Limited
Watch Aspen Pharmacare explain itAspen Pharmacare Hldgs (APNHF) Q4 2026 Earnings Call · Replay · Sep 3

Aspen Pharmacare Holdings Ltd JSE:APN:

  • JSE: APN - BUSINESS UPDATE AND TRADING STATEMENT FOR THE SIX MONTHS ENDED 31 DECEMBER 2025

  • ASPEN PHARMACARE: PREVIOUSLY COMMUNICATED GUIDANCE FOR FULL YEAR, FY 2026, REMAINS UNCHANGED

  • ASPEN PHARMACARE: EXPECTS HY HEPS 400.1 TO 432.4 CENTS

  • ASPEN PHARMACARE: ONE- OFF RESTRUCTURE COSTS OF R700 MILLION RELATING TO STERILE FDF MANUFACTURING FACILITIES HAVE BEEN INCURRED IN H1

Earlier from Aspen Pharmacare

All Aspen Pharmacare news releases